German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus

von der Schulenburg J-MG, Greiner W, Jost F, Klusen N, Kubin M, Leidl R, Mittendorf T, Rebscher H, Schoeffski O, Vauth C, Volmer T, et al. (2008)
VALUE IN HEALTH 11(4): 539-544.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Erscheinungsjahr
Zeitschriftentitel
VALUE IN HEALTH
Band
11
Zeitschriftennummer
4
Seite
539-544
ISSN
PUB-ID

Zitieren

von der Schulenburg J-MG, Greiner W, Jost F, et al. German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH. 2008;11(4):539-544.
von der Schulenburg, J. - M. G., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., Mittendorf, T., et al. (2008). German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH, 11(4), 539-544. doi:10.1111/j.1524-4733.2007.00301.x
von der Schulenburg, J. - M. G., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., Mittendorf, T., Rebscher, H., Schoeffski, O., Vauth, C., et al. (2008). German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH 11, 539-544.
von der Schulenburg, J.-M.G., et al., 2008. German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH, 11(4), p 539-544.
J.-M.G. von der Schulenburg, et al., “German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus”, VALUE IN HEALTH, vol. 11, 2008, pp. 539-544.
von der Schulenburg, J.-M.G., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., Mittendorf, T., Rebscher, H., Schoeffski, O., Vauth, C., Volmer, T., Wahler, S., Wasem, J., Weber, C.: German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. VALUE IN HEALTH. 11, 539-544 (2008).
von der Schulenburg, J. -Matthias Graf, Greiner, Wolfgang, Jost, Fred, Klusen, Norbert, Kubin, Maria, Leidl, Reiner, Mittendorf, Thomas, Rebscher, Herbert, Schoeffski, Oliver, Vauth, Christoph, Volmer, Timm, Wahler, Steffen, Wasem, Juergen, and Weber, Christian. “German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus”. VALUE IN HEALTH 11.4 (2008): 539-544.

66 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Practical issues in handling data input and uncertainty in a budget impact analysis.
Nuijten MJ, Mittendorf T, Persson U., Eur J Health Econ 12(3), 2011
PMID: 20364289
Health burden and costs of obesity and overweight in Germany.
Konnopka A, Bödemann M, König HH., Eur J Health Econ 12(4), 2011
PMID: 20401679
Cost of low back pain in Switzerland in 2005.
Wieser S, Horisberger B, Schmidhauser S, Eisenring C, Brügger U, Ruckstuhl A, Dietrich J, Mannion AF, Elfering A, Tamcan O, Müller U., Eur J Health Econ 12(5), 2011
PMID: 20526649
Nutrition economics - characterising the economic and health impact of nutrition.
Lenoir-Wijnkoop I, Dapoigny M, Dubois D, van Ganse E, Gutiérrez-Ibarluzea I, Hutton J, Jones P, Mittendorf T, Poley MJ, Salminen S, Nuijten MJ., Br J Nutr 105(1), 2011
PMID: 20797310
Health care costs and their predictors of inflammatory bowel diseases in Germany.
Prenzler A, Bokemeyer B, von der Schulenburg JM, Mittendorf T., Eur J Health Econ 12(3), 2011
PMID: 20967482
Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany.
Neilson AR, Sieper J, Deeg M., Rheumatology (Oxford) 49(11), 2010
PMID: 20660498
General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals.
Goeree R, O'Reilly D, Hopkins R, Blackhouse G, Tarride JE, Xie F, Lim M., Expert Rev Pharmacoecon Outcomes Res 10(4), 2010
PMID: 20715915
Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of men.
Haring R, Baumeister SE, Völzke H, Kohlmann T, Marschall P, Flessa S, Nauck M, Wallaschofski H., Int J Androl 33(6), 2010
PMID: 20059581
Methods of economic evaluation for the German statutory healthcare system.
Mittendorf T, Greiner W, von der Schulenburg JM., Pharmacoeconomics 27(3), 2009
PMID: 19354346
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting.
Mittendorf T, Smith-Palmer J, Timlin L, Happich M, Goodall G., Diabetes Obes Metab 11(11), 2009
PMID: 19732121
Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany.
Braun S, Mittendorf T, Menschik T, Greiner W, von der Schulenburg JM., Breast Care (Basel) 4(6), 2009
PMID: 20877674

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 18194408
PubMed | Europe PMC

Suchen in

Google Scholar